{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:37:37Z","timestamp":1778254657128,"version":"3.51.4"},"update-to":[{"DOI":"10.12688\/f1000research.153569.1","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000}},{"DOI":"10.12688\/f1000research.153569.2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000}}],"reference-count":99,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns3:p>Preterm birth is a major cause of perinatal complications and neonatal deaths. Furthermore, in the field of obstetrics many clinical entities like uterine contractions or the occurrence of pre- eclampsia remain to be serious complications during pregnancy and represent a major psychological, financial, and economic burden for society. Several published guidelines, studies and recommendations have highlighted the importance of supplementation of omega-3 long chain polyunsaturated fatty acids (PUFAs) during pregnancy. This narrative review aims at giving an overview on the modern perception of inflammatory processes and the role of specialized pro-resolving mediators (SPMs) in their resolution, especially in obstetrics. Additionally, we highlight the possible role of SPMs in the prevention of obstetric complications through oral supplementation using enriched marine oil nutritional\u2019s. The intake of PUFAs may result in an overall improvement of pregnancy outcomes by contributing to fetal brain growth and neurological development but more importantly though modulation of inflammation-associated pathologies. Especially the use of SPMs represents a promising approach for the management of obstetric and perinatal complications. SPMs are monohydroxylates derived from enriched marine oil nutritional\u2019s that involve certain pro-resolutive metabolites of omega-3 long chains PUFAs and may contribute to an attenuation of inflammatory diseases. This may be obtained through various mechanisms necessary for a proper resolution of inflammation such as the termination of neutrophil tissue infiltration, initiation of phagocytosis, downregulation of pro-inflammatory cytokines or tissue regeneration. In this way, acute and chronic inflammatory diseases associated with serious obstetrical complications can be modulated, which might contribute to an improved pregnancy outcome.<\/ns3:p>","DOI":"10.12688\/f1000research.153569.3","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T09:20:07Z","timestamp":1734945607000},"page":"882","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Omega-3 long chain fatty acids and their metabolites in pregnancy outcomes for the modulation of maternal inflammatory- associated causes of preterm delivery, chorioamnionitis and preeclampsia"],"prefix":"10.12688","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9551-2847","authenticated-orcid":false,"given":"Pedro Antonio","family":"Regidor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Eiblwieser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Steeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Miguel","family":"Rizo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"3438-3442","DOI":"10.1073\/pnas.86.9.3438","article-title":"Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor.","volume":"86","author":"K Badr","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"8-15","DOI":"10.1016\/j.tjog.2019.11.002","article-title":"Efficacy of n-3 fatty acids supplementation on the prevention of pregnancy induced-hypertension or preeclampsia: A systematic review and meta-analysis.","volume":"59","author":"F Bakouei","year":"2020","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1029-1036","DOI":"10.4049\/jimmunol.164.2.1029","article-title":"Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis- infected rats: relationship with concurrent eosinophilia.","volume":"164","author":"C Bandeira-Melo","year":"2000","journal-title":"J. Immunol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"174ra26","DOI":"10.1126\/scitranslmed.3004812","article-title":"Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma.","volume":"5","author":"C Barnig","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"282-290","DOI":"10.2350\/09-06-0659-OA.1","article-title":"Placental chorioamnionitis at term: epidemiology and follow-up in childhood.","volume":"13","author":"D Becroft","year":"2010","journal-title":"Pediatr. Dev. Pathol."},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2022.102495","article-title":"ISSFAL statement number 7 - Omega-3 fatty acids during pregnancy to reduce preterm birth.","volume":"186","author":"K Best","year":"2022","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2967-2979","DOI":"10.1096\/fj.11-185017","article-title":"Lipoxin A(4) and benzo-lipoxin A(4) attenuate experimental renal fibrosis.","volume":"25","author":"E Borgeson","year":"2011","journal-title":"FASEB J."},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.3390\/nu9121364","article-title":"Omega-3 Long-Chain Polyunsaturated Fatty Acids and Preeclampsia: Trials Say \u201cNo,\u201d but Is It the Final Word?","volume":"9","author":"D Burchakov","year":"2017","journal-title":"Nutrients."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"100905","DOI":"10.1016\/j.eclinm.2021.100905","article-title":"Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: A randomised, double-blind, adaptive-design superiority trial.","volume":"36","author":"S Carlson","year":"2021","journal-title":"EClinicalMedicine."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"101251","DOI":"10.1016\/j.ajogmf.2023.101251","article-title":"Omega-3 fatty acid supply in pregnancy for risk reduction of preterm and early preterm birth.","volume":"6","author":"I Cetin","year":"2024","journal-title":"Am. J. Obstet. Gynecol. MFM."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fimmu.2015.00263","article-title":"Much More than M1 and M2 Macrophages, There are also CD169(+) and TCR(+) Macrophages.","volume":"6","author":"L Chavez-Galan","year":"2015","journal-title":"Front. Immunol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"826-837","DOI":"10.1038\/nri2873","article-title":"Sterile inflammation: sensing and reacting to damage.","volume":"10","author":"G Chen","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"5294-5311","DOI":"10.1172\/JCI129448","article-title":"Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions.","volume":"129","author":"N Chiang","year":"2019","journal-title":"J. Clin. Invest."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"353ra111","DOI":"10.1126\/scitranslmed.aaf7483","article-title":"Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses.","volume":"8","author":"V Chiurchiu","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fimmu.2018.00038","article-title":"Bioactive Lipids and Chronic Inflammation: Managing the Fire Within.","volume":"9","author":"V Chiurchiu","year":"2018","journal-title":"Front. Immunol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"50-57","DOI":"10.1016\/j.jri.2008.04.002","article-title":"Inflammatory processes in preterm and term parturition.","volume":"79","author":"I Christiaens","year":"2008","journal-title":"J. Reprod. Immunol."},{"key":"ref13","first-page":"163-171","article-title":"Omega-3 Fatty acids and pregnancy.","volume":"3","author":"J Coletta","year":"2010","journal-title":"Rev. Obstet. Gynecol."},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2020.105187","article-title":"An overview of adult health outcomes after preterm birth.","volume":"150","author":"C Crump","year":"2020","journal-title":"Early Hum. Dev."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"44-50.e1","DOI":"10.1016\/j.jpeds.2020.05.040","article-title":"Trends in Perinatal Practices and Neonatal Outcomes of Very Low Birth Weight Infants during a 16-year Period at NEOCOSUR Centers.","volume":"225","author":"I D\u2019apremont","year":"2020","journal-title":"J. Pediatr."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia.","volume":"9","author":"E Dimitriadis","year":"2023","journal-title":"Nat. Rev. Dis. Primers."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"449-456","DOI":"10.3109\/10641955.2014.931419","article-title":"Expression of lipoxin A4, TNFalpha and IL-1beta in maternal peripheral blood, umbilical cord blood and placenta, and their significance in pre-eclampsia.","volume":"33","author":"W Dong","year":"2014","journal-title":"Hypertens Pregnancy."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2792-2801","DOI":"10.1096\/fj.201500155R","article-title":"Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.","volume":"30","author":"T Elajami","year":"2016","journal-title":"FASEB J."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"98-104","DOI":"10.1016\/j.plefa.2017.09.017","article-title":"The role of specialized pro-resolving mediators in maternal-fetal health.","volume":"126","author":"E Elliott","year":"2017","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"663-671","DOI":"10.1016\/j.ijdevneu.2011.02.011","article-title":"Intrauterine inflammation, insufficient to induce parturition, still evokes fetal and neonatal brain injury.","volume":"29","author":"M Elovitz","year":"2011","journal-title":"Int. J. Dev. Neurosci."},{"key":"ref17","article-title":"ExelVit\u00ae Esencial, Instructions for Use."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e0162506","DOI":"10.1371\/journal.pone.0162506","article-title":"Cross-Country Individual Participant Analysis of 4.1 Million Singleton Births in 5 Countries with Very High Human Development Index Confirms Known Associations but Provides No Biologic Explanation for 2\/3 of All Preterm Births.","volume":"11","author":"D Ferrero","year":"2016","journal-title":"PLoS One."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"107670","DOI":"10.1016\/j.pharmthera.2020.107670","article-title":"Carcinogenesis: Failure of resolution of inflammation?","volume":"218","author":"A Fishbein","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"S182-S192","DOI":"10.1038\/sj.bjp.0706506","article-title":"Prostaglandins, bioassay and inflammation.","volume":"147 Suppl 1","author":"R Flower","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref21","first-page":"1-166","article-title":"Fats and fatty acids in human nutrition. Report of an expert consultation.","volume":"91","year":"2010","journal-title":"FAO Food Nutr. Pap."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"221-225","DOI":"10.1016\/j.plefa.2013.07.001","article-title":"The effect of omega-3 polyunsaturated fatty acids on the inflammatory response of the amnion.","volume":"89","author":"L Frew","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1515-1528","DOI":"10.1016\/0002-9378(92)91628-N","article-title":"A review of premature birth and subclinical infection.","volume":"166","author":"R Gibbs","year":"1992","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3-7","DOI":"10.1111\/aji.12443","article-title":"Intra-Amniotic Administration of HMGB1 Induces Spontaneous Preterm Labor and Birth.","volume":"75","author":"N Gomez-Lopez","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"177-194","DOI":"10.1111\/1471-0528.16544","article-title":"Controversies in the prevention of spontaneous preterm birth in asymptomatic women: an evidence summary and expert opinion.","volume":"128","author":"L Goodfellow","year":"2021","journal-title":"BJOG."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"229-237","DOI":"10.1097\/00006250-198602000-00013","article-title":"Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis.","volume":"67","author":"M Gravett","year":"1986","journal-title":"Obstet. Gynecol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"144-150","DOI":"10.1016\/S1471-4906(01)02154-8","article-title":"Prostaglandins as modulators of immunity.","volume":"23","author":"S Harris","year":"2002","journal-title":"Trends Immunol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock.","volume":"2","author":"R Hotchkiss","year":"2016","journal-title":"Nat. Rev. Dis. Primers."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"R143-R152","DOI":"10.1530\/REP-13-0376","article-title":"Maternal dietary omega-3 fatty acids and placental function.","volume":"147","author":"M Jones","year":"2014","journal-title":"Reproduction."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"S29-S52","DOI":"10.1016\/j.ajog.2015.08.040","article-title":"Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance.","volume":"213","author":"C Kim","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"873-877","DOI":"10.1017\/S0007114507764747","article-title":"Dietary fat intakes for pregnant and lactating women.","volume":"98","author":"B Koletzko","year":"2007","journal-title":"Br. J. Nutr."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"5-14","DOI":"10.1515\/JPM.2008.001","article-title":"The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations.","volume":"36","author":"B Koletzko","year":"2008","journal-title":"J. Perinat. Med."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1262-1282","DOI":"10.1055\/a-0713-1058","article-title":"Diet and Lifestyle Before and During Pregnancy\u2014Practical Recommendations of the Germany-wide Healthy Start\u2014Young Family Network.","volume":"78","author":"B Koletzko","year":"2018","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"612-619","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution.","volume":"2","author":"B Levy","year":"2001","journal-title":"Nat. Immunol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"278-293","DOI":"10.1111\/j.1476-5381.2011.01345.x","article-title":"The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats.","volume":"164","author":"J Lima-Garcia","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"677-685","DOI":"10.1016\/j.reprotox.2012.09.009","article-title":"Treatment of Lipoxin A(4) and its analogue on low-dose endotoxin induced preeclampsia in rat and possible mechanisms.","volume":"34","author":"F Lin","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"17-23","DOI":"10.1159\/000221379","article-title":"Effects of lipoxin A(4) on CoCl(2)-induced angiogenesis and its possible mechanisms in human umbilical vein endothelial cells.","volume":"84","author":"S Liu","year":"2009","journal-title":"Pharmacology."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"3296-3307","DOI":"10.1096\/fj.201600583R","article-title":"Lipidomic analysis of patients with microbial invasion of the amniotic cavity reveals up-regulation of leukotriene B4.","volume":"30","author":"K Maddipati","year":"2016a","journal-title":"FASEB J."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1906-1916","DOI":"10.1194\/jlr.P069096","article-title":"Clinical chorioamnionitis at term: the amniotic fluid fatty acyl lipidome.","volume":"57","author":"K Maddipati","year":"2016b","journal-title":"J. Lipid Res."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"947-959","DOI":"10.1111\/j.1476-5381.2009.00386.x","article-title":"Lipoxins: resolutionary road.","volume":"158","author":"P Maderna","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1035-1045","DOI":"10.1056\/NEJMoa1816832","article-title":"A Randomized Trial of Prenatal n-3 Fatty Acid Supplementation and Preterm Delivery.","volume":"381","author":"M Makrides","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"611-615","DOI":"10.1038\/jp.2014.81","article-title":"Chorioamnionitis: epidemiology of newborn management and outcome United States 2008.","volume":"34","author":"M Malloy","year":"2014","journal-title":"J. Perinatol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"5374-5381","DOI":"10.4049\/jimmunol.0802259","article-title":"ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis.","volume":"182","author":"V Martins","year":"2009","journal-title":"J. Immunol."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"3595-3606","DOI":"10.1096\/fj.08-112201","article-title":"Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators.","volume":"22","author":"A Merched","year":"2008","journal-title":"FASEB J."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"12-24","DOI":"10.1159\/000326890","article-title":"Nutrigenetic disruption of inflammation- resolution homeostasis and atherogenesis.","volume":"4","author":"A Merched","year":"2011","journal-title":"J. Nutrigenet. Nutrigenomics."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"CD003402","DOI":"10.1002\/14651858.CD003402.pub3","article-title":"Omega-3 fatty acid addition during pregnancy.","volume":"2018","author":"P Middleton","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"55-61","DOI":"10.1111\/ajo.13405","article-title":"The health and educational costs of preterm birth to 18 years of age in Australia.","volume":"62","author":"J Newnham","year":"2022","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"795-808","DOI":"10.1097\/00003081-199312000-00004","article-title":"Chorioamnionitis and intraamniotic infection.","volume":"36","author":"E Newton","year":"1993","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"325-333","DOI":"10.1016\/j.ebiom.2018.07.009","article-title":"Plasma Concentrations of Long Chain N-3 Fatty Acids in Early and Mid-Pregnancy and Risk of Early Preterm Birth.","volume":"35","author":"S Olsen","year":"2018","journal-title":"EBioMedicine."},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.102619","article-title":"Corrigendum to \u2018Plasma concentrations of long chain N-3 fatty acids in early and mid-pregnancy and risk of early preterm birth\u2019.","volume":"51","author":"S Olsen","year":"2020","journal-title":"EBioMedicine."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1056-1067","DOI":"10.1100\/tsw.2011.98","article-title":"Effect of lipoxin A4 on lipopolysaccharide-induced endothelial hyperpermeability.","volume":"11","author":"H Pang","year":"2011","journal-title":"ScientificWorldJournal."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"506-519","DOI":"10.1002\/path.4050","article-title":"Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation.","volume":"228","author":"X Qu","year":"2012","journal-title":"J. Pathol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1036-1042","DOI":"10.4049\/jimmunol.1103483","article-title":"Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells.","volume":"189","author":"S Ramon","year":"2012","journal-title":"J. Immunol."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"518-522","DOI":"10.1016\/S1297-9589(01)00180-1","article-title":"The pathogenesis of pre-eclampsia.","volume":"29","author":"C Redman","year":"2001","journal-title":"Gynecol. Obstet. Fertil."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1592-1594","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia.","volume":"308","author":"C Redman","year":"2005","journal-title":"Science."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"986-1000","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation.","volume":"31","author":"E Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"77-98","DOI":"10.1515\/jpm-2015-0103","article-title":"Clinical chorioamnionitis at term IV: the maternal plasma cytokine profile.","volume":"44","author":"R Romero","year":"2016a","journal-title":"J. Perinat. Med."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"23-32","DOI":"10.1515\/jpm-2015-0044","article-title":"Clinical chorioamnionitis at term III: how well do clinical criteria perform in the identification of proven intra-amniotic infection?","volume":"44","author":"R Romero","year":"2016b","journal-title":"J. Perinat. Med."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"558-567","DOI":"10.3109\/14767058.2011.599083","article-title":"Clinical chorioamnionitis is characterized by changes in the expression of the alarmin HMGB1 and one of its receptors, sRAGE.","volume":"25","author":"R Romero","year":"2012","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"760-765","DOI":"10.1126\/science.1251816","article-title":"Preterm labor: one syndrome, many causes.","volume":"345","author":"R Romero","year":"2014","journal-title":"Science."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"021-039","DOI":"10.1055\/s-2006-956773","article-title":"The role of inflammation and infection in preterm birth.","volume":"25","author":"R Romero","year":"2007a","journal-title":"Semin. Reprod. Med."},{"key":"ref64","doi-asserted-by":"crossref","first-page":"S194-S202","DOI":"10.1301\/nr.2007.dec.S194-S202","article-title":"Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury.","volume":"65","author":"R Romero","year":"2007b","journal-title":"Nutr. Rev."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"19-36","DOI":"10.1515\/jpm-2014-0249","article-title":"Clinical chorioamnionitis at term I: microbiology of the amniotic cavity using cultivation and molecular techniques.","volume":"43","author":"R Romero","year":"2015","journal-title":"J. Perinat. Med."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"509-520","DOI":"10.1007\/s00011-011-0319-4","article-title":"Inflammatory pattern recognition receptors and their ligands: factors contributing to the pathogenesis of preeclampsia.","volume":"60","author":"T Sado","year":"2011","journal-title":"Inflamm. Res."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"460-465","DOI":"10.1016\/0002-9378(90)91176-D","article-title":"Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986.","volume":"163","author":"A Saftlas","year":"1990","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"261-269","DOI":"10.1016\/S0140-6736(08)60136-1","article-title":"An overview of mortality and sequelae of preterm birth from infancy to adulthood.","volume":"371","author":"S Saigal","year":"2008","journal-title":"Lancet."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"10070-10080","DOI":"10.1074\/jbc.X112.351437","article-title":"Role of basic science in the development of new medicines: examples from the eicosanoid field.","volume":"287","author":"B Samuelsson","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1038\/s41467-018-05800-6","article-title":"Resolution of chronic inflammatory disease: universal and tissue-specific concepts.","volume":"9","author":"G Schett","year":"2018","journal-title":"Nat. Commun."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"414-420","DOI":"10.1016\/j.coph.2006.02.006","article-title":"Lipoxins and new lipid mediators in the resolution of inflammation.","volume":"6","author":"J Schwab","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"101-137","DOI":"10.1146\/annurev.immunol.25.022106.141647","article-title":"Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.","volume":"25","author":"C Serhan","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"92-101","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology.","volume":"510","author":"C Serhan","year":"2014","journal-title":"Nature."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1273-1288","DOI":"10.1096\/fj.201601222R","article-title":"Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms.","volume":"31","author":"C Serhan","year":"2017","journal-title":"FASEB J."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"632-640","DOI":"10.1016\/j.coph.2013.05.012","article-title":"Resolution phase lipid mediators of inflammation: agonists of resolution.","volume":"13","author":"C Serhan","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"200-215","DOI":"10.1016\/j.smim.2015.03.004","article-title":"The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.","volume":"27","author":"C Serhan","year":"2015","journal-title":"Semin. Immunol."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"349-361","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti- inflammatory and pro-resolution lipid mediators.","volume":"8","author":"C Serhan","year":"2008a","journal-title":"Nat. Rev. Immunol."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1197-1204","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing.","volume":"192","author":"C Serhan","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"976-987","DOI":"10.1016\/j.chembiol.2011.06.008","article-title":"Novel proresolving aspirin-triggered DHA pathway.","volume":"18","author":"C Serhan","year":"2011","journal-title":"Chem. Biol."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1025-1037","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals.","volume":"196","author":"C Serhan","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"6856-6865","DOI":"10.4049\/jimmunol.171.12.6856","article-title":"Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators.","volume":"171","author":"C Serhan","year":"2003","journal-title":"J. Immunol."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"2657-2669","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators.","volume":"128","author":"C Serhan","year":"2018","journal-title":"J. Clin. Invest."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1191-1197","DOI":"10.1038\/ni1276","article-title":"Resolution of inflammation: the beginning programs the end.","volume":"6","author":"C Serhan","year":"2005","journal-title":"Nat. Immunol."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"279-312","DOI":"10.1146\/annurev.pathmechdis.3.121806.151409","article-title":"Anti-inflammatory and proresolving lipid mediators.","volume":"3","author":"C Serhan","year":"2008b","journal-title":"Annu. Rev. Pathol."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"975-981","DOI":"10.1111\/1471-0528.16168","article-title":"Omega-3 fatty acid supplementation in pregnancy-baseline omega-3 status and early preterm birth: exploratory analysis of a randomised controlled trial.","volume":"127","author":"L Simmonds","year":"2020","journal-title":"BJOG."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"75-90","DOI":"10.1161\/CIRCRESAHA.119.315506","article-title":"Enriched Marine Oil Supplements Increase Peripheral Blood Specialized Pro-Resolving Mediators Concentrations and Reprogram Host Immune Responses: A Randomized Double-Blind Placebo-Controlled Study.","volume":"126","author":"P Souza","year":"2020","journal-title":"Circ. Res."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1693-1704","DOI":"10.1084\/jem.185.9.1693","article-title":"Aspirin- triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.","volume":"185","author":"T Takano","year":"1997","journal-title":"J. Exp. Med."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"177-187","DOI":"10.1159\/000320170","article-title":"Chorioamnionitis: important risk factor or innocent bystander for neonatal outcome?.","volume":"99","author":"W Thomas","year":"2011","journal-title":"Neonatology."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"339-354","DOI":"10.1016\/j.clp.2010.02.003","article-title":"Diagnosis and management of clinical chorioamnionitis.","volume":"37","author":"A Tita","year":"2010","journal-title":"Clin. Perinatol."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"151390","DOI":"10.1016\/j.semperi.2021.151390","article-title":"Preterm birth lifetime costs in the United States in 2016: An update.","volume":"45","author":"N Waitzman","year":"2021","journal-title":"Semin. Perinatol."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"8-16","DOI":"10.1046\/j.1471-0528.2003.00012.x","article-title":"Neonatal complications following preterm birth.","volume":"110 Suppl 20","author":"R Ward","year":"2003","journal-title":"BJOG."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"282-290.e4","DOI":"10.1016\/j.fertnstert.2014.03.056","article-title":"Preeclampsia is associated with a deficiency of lipoxin A4, an endogenous anti-inflammatory mediator.","volume":"102","author":"Z Xu","year":"2014","journal-title":"Fertil Steril."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"173-192","DOI":"10.1146\/annurev-pathol-121808-102149","article-title":"Pathogenesis of preeclampsia.","volume":"5","author":"B Young","year":"2010","journal-title":"Annu. Rev. Pathol."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/13-882\/v3\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/13-882\/v3\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/13-882\/v3\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T02:00:13Z","timestamp":1738980013000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/13-882\/v3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":99,"URL":"https:\/\/doi.org\/10.12688\/f1000research.153569.3","relation":{"has-version":[{"id-type":"doi","id":"10.12688\/f1000research.153569.2","asserted-by":"subject"},{"id-type":"doi","id":"10.12688\/f1000research.153569.1","asserted-by":"subject"}],"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.176157.r351973","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.176157.r351973","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/13-882\/v3#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.173064.r336667, Carol Wang, The University of Newcastle, Callaghan, New South Wales, 04 Nov 2024, version 2, 1 approved, 1 approved with reservations","URL":"https:\/\/f1000research.com\/articles\/13-882\/v2#referee-response-336667","order":0,"name":"referee-response-336667","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.176157.r351973, Susan Carlson, Department of Dietetics and Nutrition, University of Kansas Medical Center, Kansas, KS, 08 Feb 2025, version 3, indexed","URL":"https:\/\/f1000research.com\/articles\/13-882\/v3#referee-response-351973","order":1,"name":"referee-response-351973","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}